K4 Elite logo K4 Elite
Home / Peptide Library / Cerluten
Emerging Research

Cerluten

Longevity & Anti-Aging · ['Cerluten (Cytomax)', 'Brain peptide bioregulator', 'Neuro-peptide complex']

A peptide-complex bioregulator derived from brain tissue, studied in Russian gerontology literature for proposed neuronal and geroprotective effects.

🔬 Research use only — not for human or veterinary use. K4 Elite does not provide dosing instructions.
Research Level
Emerging Research
Browse the store →
🧬

Cerluten is a 'cytomax' peptide bioregulator in the Khavinson tradition, described as a complex of short peptides extracted from the brain tissue of young animals. Within this framework it is grouped with tissue-specific preparations proposed to act on the organ system of origin.

The literature associates Cerluten with the central nervous system and positions it among geroprotective peptide complexes studied for effects on neuronal function during aging. As a tissue-derived complex rather than a single defined molecule, it has no consistently reported structure or PubChem identifier.

Molecular fields are therefore left blank. The summary below reflects the available scientific literature for reference purposes only.

The Khavinson-school hypothesis holds that short peptides in these complexes bind regulatory DNA sequences and modulate tissue-specific gene expression, with Cerluten proposed to influence neuronal tissue. Reported laboratory work describes effects on neuronal survival markers and antioxidant parameters.

These mechanistic accounts derive mainly from the developing research group and remain hypotheses under active investigation rather than independently established pathways.

  • Neuronal survival and central-nervous-system aging models
  • Geroprotection and lifespan-related peptide research
  • Peptide bioregulation and gene-expression hypotheses
  • Antioxidant and neuroprotective activity investigations
  • Neurophysiological and behavioral assessment studies
📋 How published studies were conducted — a research reference summarizing study designs from the literature. This is not usage, dosing, or administration guidance. K4 Elite does not provide dosing instructions; determining any research protocol is the sole responsibility of the qualified researcher.

Khavinson and colleagues have reported animal studies of brain-derived peptide complexes, describing changes in neuronal markers, oxidative-stress measures, and survival parameters in aging models. These are summarized strictly as published exploratory findings from a single research school.

Broader review work by Khavinson situates Cerluten within the cytomax peptide framework alongside other tissue bioregulators, describing proposed geroprotective activity observed in laboratory settings rather than in controlled independent trials.

Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.

CortagenCompatible
Another Khavinson neuro-oriented bioregulator studied within the same peptide framework.
EpitalonCompatible
A pineal peptide bioregulator frequently studied alongside other cytomax complexes in aging research.
CerebrolysinNeutral
Both appear in neuroscience research contexts; combined effects are not characterized.
Antioxidant small moleculesNeutral
Overlapping proposed antioxidant themes; interactions are not well described in study data.
  1. Khavinson VK. Peptides and Ageing. Neuro Endocrinol Lett 2002
  2. Anisimov VN, Khavinson VK. Peptide Bioregulation of Aging: Results and Prospects. Biogerontology 2010
  3. Khavinson VK et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021
What is Cerluten?
It is a brain-tissue-derived peptide complex from the Khavinson family of bioregulators, studied in gerontology literature for proposed neuronal and geroprotective effects.
Why are molecular data fields empty?
Cerluten is described as a multi-peptide complex, not a single defined molecule, and sources do not report a verified PubChem identifier, so no molecular data is fabricated here.
Is the research independently confirmed?
Most published data originates from one research school, so Cerluten is classified as an emerging-research compound pending broader independent study.
How does it relate to other bioregulators?
It is grouped with tissue-specific cytomax peptides such as Cortagen and pineal peptides like Epitalon within the same research framework.
Is this material for human or veterinary use?
No. It is offered strictly as a research-use-only reference material and is not intended for human consumption, medical treatment, or veterinary application.
Disclaimer: This profile summarizes published preclinical and laboratory research for reference only. It is not medical advice and makes no claim of safety or efficacy in humans. Determining any research protocol is the sole responsibility of the qualified researcher. Products are sold strictly for in-vitro research and have not been evaluated by the FDA.